Tamboli Ajim bought TRAX
May 12, 2026 · Form 4 insider transaction
Tamboli Ajim bought 13,600 shares of First Tracks Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The stock option vests as to 25% of the total shares on May 12, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.; In addition to the options to purchase a total of 13,600 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 123,700 shares of common stock, which options vest according to their terms.